Viewing Study NCT00242502

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-01-24 @ 6:16 AM
Study NCT ID: NCT00242502
Status: COMPLETED
Last Update Posted: 2013-05-06
First Post: 2005-10-18
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
None Liver Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatocellular Carcinoma View
None Liver Cancer View
None Bevacizumab View
None Anti-VEGF monoclonal antibody View
None rhuMAb-VEGF View
None Erlotinib Hydrochloride View
None OSI-774 View
None Tarceva View
None Erlotinib View
None Avastin View